Condition
Nodular BCC
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Tsk001 Injectable Solution Of Glucosefunctionalised Plasmonic Gold Nanoparticles 03 Mg In 1 Ml Water For Injection For Intratumoural Administration
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Tsk001 Injectable Solution Of Glucosefunctionalised Plasmonic Gold Nanoparticles 03 Mg In 1 Ml Water For Injection For Intratumoural Administration1
- 808 Nm Nearinfrared Nir Diode Laser Hyper Diode 8081
Active Sponsors
- Torskal Sas1